PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

An immunosuppressive drug could delay the onset of neurodegenerative diseases

Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's

2012-10-15
(Press-News.org) Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's. This is the main conclusion of a study published in the Nature in which has collaborated the researcher Isidro Ferrer, head of the group of Neuropathology at the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital and Full Professor of Pathological Anatomy at the University of Barcelona. The research was led by researchers from the International School for Advanced Studies (SISSA) in Trieste (Italy).

The collaboration of the research group led by Dr. Ferrer with SISSA researchers began five years ago when they observed that Parkinson's patients showed a deficit in UCHL1 protein. At that time, researchers didn't know what mechanism produced this deficit. To discover it a European project was launched. It was coordinated by the Italian researchers and participated by other European research groups, including the group led by Dr. Ferrer. The project, called Dopaminet, focused on how dopaminergic neurons (brain cells whose neurotransmitter is dopamine) are involved in Parkinson's disease.

Contrary to most common hypothesis that a DNA fragment encodes a protein through a messenger RNA molecule, the researchers found that it also works in reverse. They found a balance between the protein and its mirror protein, which is configured in reverse, and they are mutually controlled. If the protein mirror is located in the nucleus of the cell, it does not interact with the protein, while if it is in the cytoplasm, then both of them interact.

In the case of Parkinson's disease the protein UCHL1 appears reduced and also its mirror protein is localized in the nucleus, and in the cytoplasm. Thus, the researchers sought a method to extract the mirror protein from the nucleus and made it interact with the original UCHL1 protein. The authors found that rapamycin was able to extract them from the nucleus. The drug allows the two proteins, the UCHL1 and its mirror, hold together in the cytoplasm, which would correct the mistakes that occur in Parkinson's disease.

This in vitro research has allowed describing a new unknown mechanism. It is necessary that the UCHL1 mirror protein should accumulate in the nucleus and escape from the cytoplasm and join the UCLH1 protein. The combination of both makes the system work.

"The rapamycin can not cure Parkinson's disease, but it may delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's itself. Rapamycin can protect and delay the beginning of these diseases. It can complete the treatment, but it should be combined with other existing treatments", explains Isidro Ferrer.

Anyway, it is still far its application in patients. The next step is to validate these results in animal models and study the effects of rapamycin in combination with other drugs.

### About Us

The Bellvitge Biomedical Research Institute (IDIBELL) is a research center created in 2004 and it is participated by the Bellvitge University Hospital, the Catalan Institute of Health, the Catalan Institute of Oncology, and the University of Barcelona. IDIBELL is located at Biopol'H at L'Hospitalet de Llobregat and is member of the Health Universtitat de Barcelona Campus.

Article reference

Claudia Carrieri, Laura Cimatti, Marta Biagioli, Anne Beugnet, Silvia Zucchelli, Stefania Fedele, Elisa Pesce,Isidre Ferrer, Licio Collavin, Claudio Santoro, Alistair R. R. Forrest, Piero Carninci, Stefano Biffo, Elia Stupka & Stefano Gustincich. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. DOI: 10.1038/nature11508


ELSE PRESS RELEASES FROM THIS DATE:

Bicycle helmets prevent fatal head injuries

2012-10-15
Cyclists who died of a head injury were three times as likely to not be wearing a helmet compared with those who died of other injuries, according to a study in CMAJ (Canadian Medical Association Journal). "We saw an association between dying as a result of sustaining head injury and not wearing a helmet," states Dr. Navindra Persaud, Keenan Research Centre and the Department of Family and Community Medicine, St. Michael's Hospital, Toronto, with coauthors. "These results are consistent with a protective effect of helmets on cycling deaths." There is scant evidence ...

'Mother's kiss' safe and effective for removing foreign objects from children's noses

2012-10-15
A technique called the "mother's kiss" for removing foreign objects from the nasal passages of young children appears to be a safe and effective approach, found a study published in CMAJ (Canadian Medical Association Journal). "The mother's kiss appears to be a safe and effective technique for first-line treatment in the removal of a foreign body from the nasal cavity," writes Dr. Stephanie Cook, Buxted Medical Centre, Buxted, United Kingdom, with coauthors. "In addition, it may prevent the need for general anesthesia in some cases." The technique, known since the ...

Scratching the surface of psoriasis

2012-10-15
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 ...

JCI early table of contents for Oct. 15, 2012

2012-10-15
Scratching the surface of psoriasis Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate. In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. ...

Mice at risk of asthma, allergies can fight off skin cancer

2012-10-15
A molecule involved in asthma and allergies has now been shown to make mice resistant to skin cancer, according to scientists at Washington University School of Medicine in St. Louis. The molecule, called TSLP (thymic stromal lymphopoietin), is produced by damaged skin and activates the immune system. Chronic low levels of TSLP are suspected in making the immune system oversensitive to what should be a harmless environment, leading to the skin rashes and overproduction of mucus common in allergies and asthma. "But at extremely high levels, TSLP appears to train the ...

New approaches in the treatment of alcohol dependence

2012-10-15
"Addiction is a brain disease" was the title of an editorial in the renowned journal "Science" 15 years ago. The author argued that recognising addiction as a disorder of the brain can impact society´s overall health and social policy strategies and help diminish the health and social costs associated with drug abuse and addiction (Leshner, 1997). Such a presentation of the complex concept of addiction was revolutionary, as social and psychological aspects were largely considered as the most important, although not the only ones involved. Some years later, clinicians ...

Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair

2012-10-15
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. It is the first report of both androgen-dependence of exercise on nerve regeneration and of an androgenic effect of exercise in females. "The findings will provide a basis for the development of future treatment strategies for patients suffering peripheral nerve injuries," said Dale Sengelaub, professor in the Department of Psychological and Brain ...

University of Tennessee study confirms solar wind as source for moon water

University of Tennessee study confirms solar wind as source for moon water
2012-10-15
Three years ago University of Tennessee, Knoxville, researchers helped to discover water on the surface of the moon. Now, they are piecing together the origin of that water: solar wind. A new study confirms solar wind as a source for water embedded in the lunar surface. Solar wind is the continuous flow of charged particles from the sun. Scientists have speculated it to be responsible for water on the surface of the moon. Last year Larry Taylor, distinguished professor in the Department of Earth and Planetary Sciences, confirmed comets as the source for water ...

LA BioMed's Dr. Virender Rehan studies maternal nicotine's effects on unborn children and asthma

2012-10-15
LOS ANGELES (Oct. 15, 2012) – Currently, there are approximately 25 million people in the United States who suffer from the lifelong effects of asthma – wheezing, breathlessness, tightness in the chest, coughing – and the numbers are rising each year. According to the Centers for Disease Control and Prevention (CDC), the number of people in the United States diagnosed with asthma grew by 4.3 million from 2001 to 2009. Approximately 1 in 10 children and 1 in 12 adults suffer from asthma; the numbers are even higher among racial/ethnic groups, with 1 in 6 children in the ...

Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance

2012-10-15
Contact: Coimbra Sirica csirica@burnesscommunications.com 44-743-538-4915 Burness Communications Annmarie Leadman aleadman@aeras.org 301-332-8252 Aeras Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance As World Health Organization prepares to release report on global TB incidence, researchers say UK at forefront of efforts to develop critical medical tools London (October 15, 2012) – Drawing on recent findings of a significant rise in cases of drug-resistant tuberculosis in the UK and globally, top TB researchers ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] An immunosuppressive drug could delay the onset of neurodegenerative diseases
Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of diseases such as Alzheimer's or Parkinson's